Medical support is one of the essential safety conditions for isolation or confinement experiments, as it enables the timely arrangement of actions to preserve the health of crew members and volunteers. Such analog experiments allow the testing of prospective medical technologies and methods for health support in long-term space missions and on-planet stations. In the current paper, we report the results of the medical control within the medical support system of the two model isolation experiments of the SIRIUS series, lasting for 4 and 8 months, respectively. The results indicate the prevalence of headache complaints, skin inflammatory reactions, and sleep disturbance during the longer confinement experiment. In addition, signs of vitamin D deficiency were revealed in 10 of the 12 objects. The data exchange with the scientific branch of the experiments provides for the in-time detection of early symptoms of disease, using samples of blood, urine, saliva, epithelia, etc. However, the issues of medical data confidence and, subsequently, of the crew members’ compliance with the medical staff, become pointed. In general, the work demonstrates the expediency of the investigations, including the data collection and analysis of the medical control indicators in further experiments, for the optimization of the medical support of both the analogous research projects and the development of the recommendations for the medical support of small autonomous groups, such as manned space missions.